Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Prepaid Assets (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Prepaid Assets data on record, last reported at $2.8 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 21.26% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $2.8 million, up 21.26%, while the annual FY2025 figure was $2.8 million, 21.26% up from the prior year.
  • Prepaid Assets reached $2.8 million in Q4 2025 per VRCA's latest filing, down from $3.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $4.4 million in Q4 2022 and bottomed at $1.5 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $2.9 million, with a median of $2.8 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: tumbled 46.28% in 2023, then skyrocketed 69.13% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $4.0 million in 2021, then grew by 9.59% to $4.4 million in 2022, then crashed by 41.56% to $2.5 million in 2023, then decreased by 9.23% to $2.3 million in 2024, then grew by 21.26% to $2.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $2.8 million in Q4 2025, $3.6 million in Q3 2025, and $1.5 million in Q2 2025.